Oberweis Asset Management’s AngioDynamics ANGO Stock Holding History

Oberweis Asset Management’s Portfolio ANGO Stock Details ANGO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q4	–	Sell	-207,400	Closed	-$4.24M	–	165
2022 Q3	$4.24M	Buy	207,400 +28,450	+16%	+$625K	0.99%	17
2022 Q2	$3.46M	Sell	178,950 -61,320	-26%	-$1.26M	0.88%	17
2022 Q1	$5.17M	Buy	240,270 +36,060	+18%	+$818K	1.04%	13
2021 Q4	$5.63M	Buy	204,210 +97,810	+92%	+$2.7M	1.03%	16
2021 Q3	$2.76M	Buy	106,400 +8,100	+8%	+$217K	0.57%	25
2021 Q2	$2.67M	Hold	98,300	–	–	0.58%	27
2021 Q1	$2.3M	Buy	+98,300	New	+$1.99M	0.47%	31

Other funds holding ANGO

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Victory Capital Management San Antonio, Texas $156B AUM 27.51% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

SFM

Systematic Financial Management Teaneck, New Jersey $4.36B AUM 40.56% 1-Year Est. Return

Balyasny Asset Management Chicago, Illinois $77.1B AUM 42.89% 1-Year Est. Return

Manulife (Manufacturers Life Insurance) Canada, Ontario, Canada $116B AUM 26.37% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Oberweis Asset Management's ANGO Position: Q4 2022 in Review

Oberweis Asset Management sold out of AngioDynamics (ANGO) in Q4 2022, closing a stake of 207,400 shares — an estimated $4.24M sold.

Oberweis Asset Management first reported a position in ANGO in Q1 2021 and held it in 7 quarters. The position peaked at $5.63M in Q4 2021. 149 funds tracked by Wall St. Rank hold ANGO as of Q4 2022.

Oberweis Asset Management reported no remaining AngioDynamics position as of Q4 2022 after selling out during the quarter.
Oberweis Asset Management sold 207,400 AngioDynamics shares in Q4 2022, an estimated $4.24M.
Oberweis Asset Management first reported a position in AngioDynamics in Q1 2021 and held it in 7 quarters.
Oberweis Asset Management's AngioDynamics position peaked at $5.63M in Q4 2021.
149 funds tracked by Wall St. Rank held AngioDynamics as of Q4 2022.

Based on Oberweis Asset Management's 13F filing for Q4 2022, filed 14 Feb 2023.